Bacil Pharma Ltd.

BACPHAR

₹37.58

4.97% (1.78)

Market Cap

₹54 Cr.

P/E

133.51

Key Ratios

Edit Ratio's

Market cap

54.00 Cr

133

Prom Holding

0.20 %

ROE (%)

-4.86

ROCE (%)

-5.03

Div Yield (%)

Sales

OPM (%)

Debt to Equity

0.08

Edit Ratio's

About

Bacil Pharma Limited, incorporated in the year 1987, is a public limited company. The main obj… Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

5 Yes

Positive for this company

0 Neutral

Neutral for this company

7 No

Negative for this company

5 No Data

Insufficient data to analyse

Accounting & Shareholding

Depreciation Effect

Depreciation accounting is not leading to increase in profits
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Promoter Holding

Promoters has been selling shares in the open market over last 90 days
Other Income

Other income component is making ratios of the company look optically better
Revenue Recognition

Unable to calculate due to limited data
Contingent Liabilities

Unable to calculate due to limited data

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
Working Capital

Working capital of the company seems to be under control
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
Debt

Company might have issues servicing its debt
Share price

Share price has increased over last 10 years but more due to rerating
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
ROE

Unable to calculate due to limited data
Current vs Historic Valuation

Unable to calculate due to limited data
Sales Growth

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Bacil Pharma Ltd. Business

What does Bacil Pharma do?

Established in 1987, Bacil Pharma Limited is a public company specializing in bulk pharmaceutical and chemical manufacturing, including heavy, medium, and fine chemicals.

Who are the competitors of Bacil Pharma?

Bacil Pharma major competitors are Concord Drugs, Lasa Supergenerics, Medicamen Organics, Kabra Drugs, Deccan Health Care, Shelter Pharma, Sandu Pharmaceutical.
Market Cap of Bacil Pharma is ₹54 Crs.
While the median market cap of its peers are ₹50 Crs.

Is Bacil Pharma financially stable compared to its competitors?

Bacil Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Bacil Pharma is 0 and is ranked 7 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Bacil Pharma Ltd.

Bacil Pharma Ltd.

Key Ratios

About

Timeline

Company Timeline

5 Yes

0 Neutral

7 No

5 No Data

Accounting & Shareholding

Depreciation Effect

Pledge

Retail Holding

Promoter Holding

Other Income

Revenue Recognition

Contingent Liabilities

Price & Performance

Capex vs ROCE

Working Capital

Balance Sheet Strength

Debt

Share price

Margin Stability

ROCE Strength

ROE

Current vs Historic Valuation

Sales Growth

Product Wise Break-Up

UNLOCK PREMIUM

What does Bacil Pharma do?

Who are the competitors of Bacil Pharma?

Is Bacil Pharma financially stable compared to its competitors?

SIGN UP FOR FREE